✦ LIBER ✦
346 POSTER CBP501, a novel cell cycle G2 checkpoint abrogator. Preliminary results of the initial phase I and pharmacokinetic (PK)/pharmacodynamic (PD) study in patients (pts) with advanced solid tumors
✍ Scribed by M.S. Gordon; J.P. Eder; D.S. Mendelson; E. Wasserman; W. Sutherland; T. Kawabe; G.I. Shapiro
- Book ID
- 118623974
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 58 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.